The AAAS gene gives your body instructions for a protein that helps move important materials in and out of the cell nucleus, the cell’s control center. This gene plays an important role in keeping certain nerve, tear gland, and adrenal cells working properly. When both copies of the AAAS gene do not work as they should because of pathogenic variants, it can cause AAA syndrome, also called triple A syndrome. People with this condition may have very dry eyes from making too few tears, trouble swallowing from achalasia, adrenal gland failure, and sometimes weakness or other nerve related symptoms.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or guide processes in the body. Some genes carry the information needed to produce proteins, which are the parts of cells that do much of the work. Other genes mainly regulate when certain processes happen, where they happen, and how active they are. As a group, genes affect how the body develops and works, and they can also shape how you respond to food, stress, and medications. You can find more on this topic in the LearnHub.
Overview
AAASGene function
What if the gene works
The AAAS gene helps make ALADIN, a protein that sits at pores in the nucleus, the cell’s control center. It supports movement of selected proteins into and out of the nucleus and helps cells handle stress.
Risk
What if the gene does not work
Pathogenic variants in the AAAS gene can cause triple A syndrome, often involving reduced tears, trouble swallowing from achalasia, and adrenal insufficiency. Milder to more severe variants may change when symptoms start and whether nerve problems also appear.
Treatment
What does that mean for your treatment
A pathogenic variant in the AAAS gene does not have a targeted gene based therapy. Treatment is guided by the problems it causes: lifelong glucocorticoid replacement, and sometimes fludrocortisone, for adrenal insufficiency, plus standard care for dry eyes and achalasia. People with AAAS related adrenal insufficiency may need stress dose steroids during illness or surgery.
Conditions associated with AAAS
Gene function
What if the gene works
Inside each cell, the AAAS gene helps manage traffic at the membrane around the nucleus, where your DNA is kept. Its protein sits in the nuclear pore, a gateway that controls which molecules move in and out. This steady movement is central to what the AAAS gene does in the body every day.
The AAAS gene helps support the nuclear pore, the doorway in the membrane around the nucleus. This gateway keeps movement into and out of the nucleus organized and selective.
Its protein helps certain proteins move between the nucleus and the rest of the cell. This controlled traffic supports normal gene activity and other routine cell tasks.
What is a variant?
A genetic variant is a slight difference in the DNA sequence within a gene. Variants are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many have no noticeable effects and simply represent natural genetic variation. In some situations, though, a variant changes gene function to a greater extent and may contribute to or lead to a genetic condition.
Genetic variants
What if the gene does not work
Many AAAS gene variants make the ALADIN protein fold poorly, become unstable, or fail to reach the cell's nuclear pore, the gateway that controls traffic into and out of the nucleus. This explains how AAAS gene variants affect protein function, from milder changes that leave some activity to more disruptive variants that produce little or no working protein. In triple A syndrome, greater loss of function can be linked to earlier onset or a wider mix of features.
How variants are linked to conditions
Pathogenic variants in the AAAS gene cause Triple A syndrome, also called Allgrove syndrome. This condition is classically linked to reduced tear production, trouble swallowing from achalasia, and adrenal insufficiency, though features can vary from person to person. Some people with AAAS gene variants linked to Triple A syndrome also develop nerve problems or autonomic symptoms, leading some clinicians to use the term 4A syndrome.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely found in the general population. Most do not have a direct effect on health and simply contribute to normal human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a confirmed diagnosis, especially when several genes and environmental factors also play a role. In some situations, though, a single well characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For AAAS-related triple A syndrome, risk is mainly set by whether someone inherits two changed copies of the AAAS gene, so day-to-day lifestyle is not known to meaningfully change the chance of having the condition. A family history of the condition or parents who are related by blood can raise the chance in a child.
Inheritance of AAAS variants
AAAS-related conditions are inherited in an autosomal recessive pattern. This means a person usually develops the condition only when they inherit two disease-causing variants in the AAAS gene, one from each parent. Parents who each carry one AAAS gene variant are usually unaffected carriers, and with each pregnancy there is a 25% chance the child will inherit both variants, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither variant. In practical terms, how AAAS gene variants are inherited often becomes clear when more than one child in a family is affected while the parents are healthy carriers.
What does my AAAS result mean for my family?
For families, an AAAS result usually means close relatives could also carry the same gene change, even if they have no symptoms. Brothers and sisters may have the same condition or be carriers, and parents are often carriers as well. Family members may want to learn whether this result is present in them too, especially when planning a family or when similar health problems have appeared in relatives.
Genetic information
Genetic testing
How you find out about variants
Genetic testing of the AAAS gene for triple A syndrome usually uses a blood or saliva sample to read the gene and look for variants. It can help confirm the genetic cause of a person’s symptoms or show whether they carry two disease-causing variants, with results interpreted alongside medical history and family findings.
When should I consider getting a genetic test?
Consider testing for the AAAS gene if someone has little or no tears, trouble swallowing because the food pipe does not relax properly, and adrenal gland problems such as low cortisol. Testing can also help when this condition runs in the family or when a child has some of these signs and the cause is unclear.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it reveals varies with the condition and the kind of variant present. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. For some conditions, particularly those shaped by many genes, genetic information provides context rather than certainty and is most useful when considered with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results can also help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. One person may break down a drug faster, while another may process it more slowly or be more sensitive to its effects. This helps explain why the same treatment can work well for some people, work less well for others, or lead to more side effects in some cases.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect the way they respond to medications. By studying links between genes and drugs, it helps explain why the same treatment may work differently in different people. For many medicines, genes can influence how the body handles a drug or how strong its effects are. This information can support treatment decisions that are more informed and more individualized. More detail is available in the LearnHub.
Drugs influenced by the AAAS gene
When should I seek medical advice?
There isn't yet a broadly confirmed role for this gene in guiding medication choice or dosing, so any concerns about symptoms, treatment, or medicine side effects are best discussed with your doctor.
History
The AAAS gene entered medical genetics through studies of families affected by triple A syndrome, also called Allgrove syndrome, a condition first described in 1978. In 2000, researchers mapped the condition to chromosome 12 and identified pathogenic variants in the AAAS gene as the cause in many affected families. From these first observations, research expanded steadily, helping connect earlier clinical reports to a specific inherited cause. The gene’s name reflects the syndrome’s initials, and the protein it encodes was later named ALADIN. Over time, descriptions became more precise as testing made it possible to confirm the diagnosis at the DNA level and recognize a wider range of features in different families.